چهارشنبه 24 اردیبهشت 1404
[Archive]
دوره 19، شماره 5 - ( 3-1400 )
جلد 19 شماره 5 صفحات 71-71 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Eslamian L. K-71 Prenatal screening and prenatal diagnosis, new challenges in Iran. IJRM 2021; 19 (5) :71-71
URL: http://ijrm.ir/article-1-2810-fa.html
URL: http://ijrm.ir/article-1-2810-fa.html
K-71 Prenatal screening and prenatal diagnosis, new challenges in Iran. International Journal of Reproductive BioMedicine. 1400; 19 (5) :71-71
چکیده: (184 مشاهده)
Approximately 3% to 5% of pregnancies are complicated by birth defects or genetic disorders. The rapid evolution of cytogenetic methods and the advancement of molecular genetics have greatly contributed to the reduction of births with genetic defects. Prenatal tests include prenatal screening tests and prenatal diagnostic tests, which aim to detect metabolic, chromosomal, and anatomical abnormalities of the fetus as soon as possible during pregnancy. In 2007 American Congress of Obstetricians and Gynecologists (ACOG) released “ACOG Practice Bulletin No. 77,” which recommended making aneuploidy screening or invasive testing available for all women, ideally at their first prenatal visit. This idea was revolutionary at the time, as previously only women who were considered to be at high risk had been offered these tests. In Iran, prenatal screening tests are considered the health care system and every pregnant woman with a positive screening is referred for prenatal diagnostic tests. But Iran is currently facing a serious challenge for PGS and PGD. The Iran parliament has decided to eliminate prenatal screening tests from PHS to prevent population decline.
نوع مطالعه: Congress Abstract |
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
